Table 2 Primary and secondary outcomes
| SBP < 130 and LVH | SBP ≥130 and LVH | SBP < 130 and no LVH | SBP ≥130 and no LVH | P value | |
|---|---|---|---|---|---|
| CVE, % | 7 (21.2) | 25 (37.9) | 7 (10.3) | 8 (10.5) | <0.0001 |
| Death, % | 3 (9) | 5 (7.58) | 4 (5.9) | 1 (1.32) | 0.25 |
| Changes in GFR during follow up (cc/min/BSA) | -5.27 ± 9.48 | -3.57 ± 12.1 | -5 ± 15.4 | -7.7 ± 13.2 | 0.31 |
| ESRD, % | 1 (3) | 4 (6) | 0 | 2 (2.63) | 0.22 |